Please note that these presentation files reflect the presenters' views at the time of their presentation. PMDA is not in the position of answering questions on the content of the files. Also please refrain from contacting the presenter regarding the contents of their presentations.

Date	Presenter	Title	Venue
October.27-29, 2010	Yoshikazu Hayashi	Regulatory requirements with regard to APIs in Japan 13th APIC/CEFIC European Conference on Active Pharmaceutical Ingredients	Barcelona
October.18, 2010	Toshiyoshi Tominaga, Ph.D	HBD: Overview of Program Past, Present & Potential AdvaMed 2010: The MedTech Conference	Washington DC
September.13, 2010	Yuki Ando Ph.D	Multi-Regional Clinical Trials in Global Drug Development: Experience in Japan APEC Multi-Regionrials Seoul Workshop	Soul
September.13, 2010	Yoshiaki Uyama Ph.D	Global Drug Development in Consideration of Ethnic Factors APEC Multi-Regionrials Seoul Workshop	Soul
March 8-10, 2010	Tatsuya Kondo, M.D., Ph.D. Chief Executive	Future Directions and Challenges of PMDA DIA 22nd Annual EuroMeeting	Monaco
March 8-10, 2010	Satoshi Toyoshima, Ph.D.Executive Director Director, Center for Product Evaluation	Current Status of New Drug Reviews and Challenges to Promote Global Drug Development DIA 22nd Annual EuroMeeting	Monaco
March 8-10, 2010	Yoshiaki Uyama, Ph.D	Current PMDA projects to promote Global Drug Development including Japan DIA 22nd Annual EuroMeeting	Monaco
Jan.10, 2010	Toshiyoshi Tominaga, Ph.D. Office Director (Office of International Programs)	China-Japan-Korea Tripartite Cooperation and Japan PMDA’s Perspective on Pharmaceutical Quality 2010 International Symposium on pharmaceutical Quality and Global Competitiveness	Beijing
Dec.18, 2009	Tatsuya Kondo, M.D., Ph.D. Chief Executive	Global Clinical Trials in East Asian countries Japan-Korea-China Drug Clinical Trial Symposium	Beijing